ClinicalTrials.Veeva

Menu

Tulsi Consumption and Its Effects on Cognition, Stress and Anxiety

C

Composite Interceptive Med Science

Status

Completed

Conditions

Cognitive Change

Treatments

Drug: Placebo
Drug: Ocimum Sanctum

Study type

Interventional

Funder types

Industry

Identifiers

NCT03184909
OI-006-2017

Details and patient eligibility

About

Tulsi and its effects on facilitative cognitive enhancement through lowering levels of stress and anxiety. A randomised placebo-controlled clinical trial.

Full description

Ocimum Sanctum or Holy Basil, commonly called Tulsi is a traditional Indian herb. It is believed to bring about a facilitative enhancement of cognitive ability and lower stress levels in individuals. Stress and an inability to perform at a required level of cognition can induce anxiety. This study is looking at the effects of daily consuming Tulsi among a group of individuals who work in an environment that demands memory, attention and executive functioning.

Enrollment

30 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects between the ages of 18 and 50 years, providing written informed consent.

Exclusion criteria

Subjects who meet the following criteria

  • Education level below 8th grade of schooling
  • Unable to read or understand English or having no working knowledge of English
  • Known history or neurological conditions that can affect cognition
  • Known history of drug abuse or potential for drug abuse, a regular consumer of alcohol or unwilling to withhold consumption of alcohol for the duration of the study.
  • A chronic smoker or consumer of other tobacco related products or is undergoing a rehabilitation program for alcohol and or tobacco consumption
  • Any history or psychiatric disorders - currently on treatment or treated in within the last 12 months
  • Any characteristic that makes the investigator uncomfortable to include the subject in the study.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

30 participants in 2 patient groups, including a placebo group

Tulsi active
Experimental group
Treatment:
Drug: Ocimum Sanctum
Tulsi placebo
Placebo Comparator group
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems